Skip to main content
MIST logo

Milestone Pharmaceuticals Inc.

MISTNASDAQHealthcareBiotechnology

$0.71Today:- (-)1Y −59.05%

As of Oct 16, 2026 close

Market cap
$110.19M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$0.71$3.06
Volume (live)
-
Avg. volume (3M)
1.32M

Milestone Pharmaceuticals Inc. (MIST) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Milestone Pharmaceuticals Inc. stock.

Analyst Consensus Rating

Investment consensus from 5 professional research analysts

Consensus Rating

Buy
Based on 5 unique analysts
Medium Confidence∞:1 Buy/Sell

Average Price Target

$6.50
+818.99% upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest MIST Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Brandon Folkes
HC Wainwright
BuyMaintains
$8.00
Olivia Brayer
Cantor Fitzgerald
BuyInitiates
$3.00
Ritu Baral
TD Cowen
BuyMaintains
$8.00
Mohit Bansal
Wells Fargo
BuyMaintains
$7.00
Zacks Equity Research
Zacks Equity Research
HoldInitiates Coverage
-

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Sep 22, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for MIST?

The analyst consensus rating for MIST is Buy, based on the latest ratings from 5 analysts over the last 90 days.

What is the average price target for MIST?

The average 12-month price target for MIST is $6.50, representing an upside of 819.0% from the Oct 16, 2026 close of $0.71.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.